ED50 and ED95 of Intrathecal Hyperbaric Bupivacaine With Fentanyl for Transurethral Prostatectomy in Elderly Patients

Sponsor
Hallym University Kangnam Sacred Heart Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03704441
Collaborator
(none)
13
1
7
22
0.6

Study Details

Study Description

Brief Summary

As people age, the incidence of prostate hyperplasia increases. So patients under Transurethral Resection of Prostate(TURP) or Holmium Laser Ennucleation of Prostate(HoLEP) are mostly ole age people. Most old age patient has several underlying disease. So patients can develop high mortality and morbidity. Most surgeries for Prostate Resection are taken under Spinal anesthesia. Adequate block level for Prostate Resection is T10. But sometimes, old age patients can develop severe complication after spinal anesthesia. So we started this study to know the adequate drug concentration for Spinal anesthesia taken for Prostate Resection surgery.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

As people age, the incidence of prostate hyperplasia increases. So patients under Transurethral Resection of Prostate(TURP) or Holmium Laser Ennucleation of Prostate(HoLEP) are mostly ole age people. Most old age patient has several underlying disease. So patients can develop high mortality and morbidity. Most surgeries for Prostate Resection are taken under Spinal anesthesia. Adequate block level for Prostate Resection is T10. But sometimes, old age patients can develop severe hypotension and vital unstability due to unintentional high sensory and motor blocks. These complications are due to the decreased cerebrospinal fluid volume with increase of age. So we started this study to know the adequate drug concentration for Spinal anesthesia taken for Prostate Resection surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
ED50 and ED95 of Intrathecal Hyperbaric Bupivacaine With Fentanyl for Transurethral Prostatectomy in Elderly Patients : a Prospective Double-blinded Randomized Trial
Actual Study Start Date :
Nov 1, 2018
Actual Primary Completion Date :
May 31, 2020
Actual Study Completion Date :
Sep 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: bupivacaine 6mg

bupivacaine 6mg

Drug: Bupivacaine
bupivacaine dose

Other: bupivacaine 7mg

bupivacaine 7mg

Drug: Bupivacaine
bupivacaine dose

Other: bupivacaine 8mg

bupivacaine 8mg

Drug: Bupivacaine
bupivacaine dose

Other: bupivacaine 9mg

bupivacaine 9mg

Drug: Bupivacaine
bupivacaine dose

Other: bupivacaine 10mg

bupivacaine 10mg

Drug: Bupivacaine
bupivacaine dose

Other: bupivacaine 11mg

bupivacaine 11mg

Drug: Bupivacaine
bupivacaine dose

Other: bupivacaine 12mg

bupivacaine 12mg

Drug: Bupivacaine
bupivacaine dose

Outcome Measures

Primary Outcome Measures

  1. ED50 and ED95 of intrathecal hyperbaric bupivacaine with fentanyl for transurethral prostatectomy in elderly patients [2years]

    ED50(50% Effective dose) and ED95(95% Effective dose) of intrathecal hyperbaric bupivacaine with fentanyl for transurethral prostatectomy in elderly patients

Secondary Outcome Measures

  1. comparison of incidence of complications(hypotension, nausea/vomiting and shivering) during perioperative period [2years]

    comparison of incidence of complications(hypotension, nausea/vomiting and shivering) during perioperative period

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 100 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients scheduled for TURP & HoLEP under spinal anesthesia

  • Male between 65 and 100

  • The American Society of Anesthesiologists physical status class 1 or 2

Exclusion Criteria:
  • Patients with coagulopathy

  • Patients with infectious disease

  • Patients with a drug allergy

  • Patients under 50kg or over 100kg

  • In case of switching to general anesthesia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kangnam sacred heart hospital Seoul Yeongdeungpo-gu Korea, Republic of KS013

Sponsors and Collaborators

  • Hallym University Kangnam Sacred Heart Hospital

Investigators

  • Study Director: Eun Mi Choi, MD, Hallym University Kangnam Sacred Heart Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hallym University Kangnam Sacred Heart Hospital
ClinicalTrials.gov Identifier:
NCT03704441
Other Study ID Numbers:
  • KangnamAnes
First Posted:
Oct 12, 2018
Last Update Posted:
Mar 21, 2022
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hallym University Kangnam Sacred Heart Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 21, 2022